US Edition
News from tickerreport.com
If you want to know if tickerreport.com is credible or reliable, look no further. We rank tickerreport.com as Unknown factuality. Find out more about our methodology here.
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top tickerreport.com News
AbbVie · United StatesInstitute for Wealth Management LLC. decreased its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.8% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 19,095 shares of the company’s stock after selling 160 shares during the quarter. Institute for Wealth Management LLC.’s holdings in AbbVie were worth $3,544,000 as of its most recent […]See the Story
AbbVie Inc. $ABBV Shares Sold by Institute for Wealth Management LLC.
Pennsylvania · PennsylvaniaFirst National Bank & Trust Co. of Newtown reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,158 shares of the healthcare product maker’s stock after selling 150 shares during the period. […]See the Story
First National Bank & Trust Co. of Newtown Decreases Holdings in Abbott Laboratories $ABT
United States · United StatesJ. Safra Sarasin Holding AG grew its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.9% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 210,754 shares of the healthcare product maker’s stock after purchasing an additional 3,904 shares during the period. J. Safra Sarasin […]See the Story
